Results

Amgen Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 12:36

FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and dexamethasone For Patients With Multiple Myeloma At[...]